{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:39:22Z","timestamp":1770813562708,"version":"3.50.1"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11897-019-00437-y","type":"journal-article","created":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T07:52:04Z","timestamp":1570866724000},"page":"189-200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Anabolism to Catabolism: Serologic Clues to Nutritional Status in Heart Failure"],"prefix":"10.1007","volume":"16","author":[{"given":"Laura","family":"Murphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emer","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,12]]},"reference":[{"issue":"10","key":"437_CR1","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/cir.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke Statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146\u2013603. \n                      https:\/\/doi.org\/10.1161\/cir.0000000000000485\n                      \n                    .","journal-title":"Circulation."},{"issue":"3","key":"437_CR2","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","volume":"6","author":"PA Heidenreich","year":"2013","unstructured":"Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606\u201319. \n                      https:\/\/doi.org\/10.1161\/HHF.0b013e318291329a\n                      \n                    .","journal-title":"Circ Heart Fail"},{"issue":"6","key":"437_CR3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/ejhf.566","volume":"18","author":"MG Crespo-Leiro","year":"2016","unstructured":"Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F, et al. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail. 2016;18(6):613\u201325. \n                      https:\/\/doi.org\/10.1002\/ejhf.566\n                      \n                    .","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"437_CR4","first-page":"101","volume":"5","author":"T Raposo Andr\u00e9","year":"2017","unstructured":"Raposo Andr\u00e9 T, Lopes-Santos A. I GN. Cardiac Cachexia syndrome. Eur Med J Cardiol. 2017;5(1):101\u20137.","journal-title":"Eur Med J Cardiol"},{"issue":"6","key":"437_CR5","doi-asserted-by":"publisher","first-page":"635.e15","DOI":"10.1016\/j.amjmed.2016.02.007","volume":"129","author":"P Goyal","year":"2016","unstructured":"Goyal P, Almarzooq ZI, Horn EM, Karas MG, Sobol I, Swaminathan RV, et al. Characteristics of Hospitalizations for Heart Failure with Preserved Ejection Fraction. Am J Med. 2016;129(6):635.e15\u201326. \n                      https:\/\/doi.org\/10.1016\/j.amjmed.2016.02.007\n                      \n                    .","journal-title":"Am J Med"},{"issue":"4","key":"437_CR6","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ahj.2013.07.008","volume":"166","author":"SM McNallan","year":"2013","unstructured":"McNallan SM, Chamberlain AM, Gerber Y, Singh M, Kane RL, Weston SA, et al. Measuring frailty in heart failure: a community perspective. Am Heart J. 2013;166(4):768\u201374. \n                      https:\/\/doi.org\/10.1016\/j.ahj.2013.07.008\n                      \n                    .","journal-title":"Am Heart J"},{"issue":"12","key":"437_CR7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/clc.22345","volume":"37","author":"MT Vidan","year":"2014","unstructured":"Vidan MT, Sanchez E, Fernandez-Aviles F, Serra-Rexach JA, Ortiz J, Bueno H. FRAIL-HF, a study to evaluate the clinical complexity of heart failure in nondependent older patients: rationale, methods and baseline characteristics. Clin Cardiol. 2014;37(12):725\u201332. \n                      https:\/\/doi.org\/10.1002\/clc.22345\n                      \n                    .","journal-title":"Clin Cardiol"},{"issue":"3","key":"437_CR8","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.m146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146\u201356. \n                      https:\/\/doi.org\/10.1093\/gerona\/56.3.m146\n                      \n                    .","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"437_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.clnu.2015.03.001","volume":"34","author":"T Cederholm","year":"2015","unstructured":"Cederholm T, Bosaeus I, Barazzoni R, Bauer J, Van Gossum A, Klek S, et al. Diagnostic criteria for malnutrition - An ESPEN Consensus Statement. Clin Nutr (Edinburgh, Scotland). 2015;34(3):335\u201340. \n                      https:\/\/doi.org\/10.1016\/j.clnu.2015.03.001\n                      \n                    .","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"issue":"2","key":"437_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.clnu.2014.03.014","volume":"34","author":"K Tevik","year":"2015","unstructured":"Tevik K, Thurmer H, Husby MI, de Soysa AK, Helvik AS. Nutritional risk screening in hospitalized patients with heart failure. Clin Nutr (Edinburgh, Scotland). 2015;34(2):257\u201364. \n                      https:\/\/doi.org\/10.1016\/j.clnu.2014.03.014\n                      \n                    .","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"issue":"11","key":"437_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","volume":"36","author":"P Ponikowski","year":"2015","unstructured":"Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiencydagger. Eur Heart J. 2015;36(11):657\u201368. \n                      https:\/\/doi.org\/10.1093\/eurheartj\/ehu385\n                      \n                    .","journal-title":"Eur Heart J"},{"issue":"5","key":"437_CR12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10741-016-9540-0","volume":"21","author":"H Lin","year":"2016","unstructured":"Lin H, Zhang H, Lin Z, Li X, Kong X, Sun G. Review of nutritional screening and assessment tools and clinical outcomes in heart failure. Heart Fail Rev. 2016;21(5):549\u201365. \n                      https:\/\/doi.org\/10.1007\/s10741-016-9540-0\n                      \n                    .","journal-title":"Heart Fail Rev"},{"issue":"1","key":"437_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.clnu.2004.07.015","volume":"24","author":"HM Kruizenga","year":"2005","unstructured":"Kruizenga HM, Seidell JC, de Vet HC, Wierdsma NJ, van Bokhorst-de van der Schueren MA. Development and validation of a hospital screening tool for malnutrition: the short nutritional assessment questionnaire (SNAQ). Clin Nutr (Edinburgh, Scotland). 2005;24(1):75\u201382. \n                      https:\/\/doi.org\/10.1016\/j.clnu.2004.07.015\n                      \n                    .","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"issue":"4","key":"437_CR14","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/jcsm.12193","volume":"8","author":"M Hajahmadi","year":"2017","unstructured":"Hajahmadi M, Shemshadi S, Khalilipur E, Amin A, Taghavi S, Maleki M, et al. Muscle wasting in young patients with dilated cardiomyopathy. J Cachexia Sarcopenia Muscle. 2017;8(4):542\u20138. \n                      https:\/\/doi.org\/10.1002\/jcsm.12193\n                      \n                    .","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"437_CR15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ijcard.2016.12.064","volume":"230","author":"N Iwakami","year":"2017","unstructured":"\u2022 Iwakami N, Nagai T, Furukawa TA, Sugano Y, Honda S, Okada A, et al. Prognostic value of malnutrition assessed by controlling nutritional status score for long-term mortality in patients with acute heart failure. Int J Cardiol. 2017;230:529\u201336. \n                      https:\/\/doi.org\/10.1016\/j.ijcard.2016.12.064\n                      \n                    \n                              This study highlights the importance of assessing nutritional status in acute HF patients due to the significant association with increased mortality identified in this group.","journal-title":"Int J Cardiol"},{"issue":"4","key":"437_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s12603-013-0030-y","volume":"17","author":"L Sargento","year":"2013","unstructured":"Sargento L, Satendra M, Almeida I, Sousa C, Gomes S, Salazar F, et al. Nutritional status of geriatric outpatients with systolic heart failure and its prognostic value regarding death or hospitalization, biomarkers and quality of life. J Nutr Health Aging. 2013;17(4):300\u20134. \n                      https:\/\/doi.org\/10.1007\/s12603-013-0030-y\n                      \n                    .","journal-title":"J Nutr Health Aging"},{"issue":"19","key":"437_CR17","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1001\/jama.2017.5427","volume":"317","author":"GD Lewis","year":"2017","unstructured":"\u2022 Lewis GD, Malhotra R, Hernandez AF, SE MN, Smith A, Felker GM, et al. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical TrialOral Iron for Heart FailureOral Iron for Heart Failure. JAMA. 2017;317(19):1958\u201366. \n                      https:\/\/doi.org\/10.1001\/jama.2017.5427\n                      \n                    \n                              The results for IV iron have previously been promising with improvements in exercise capacity in HF patients however, this study examines the use of oral iron and found it to be of little benefit in the treatment group.","journal-title":"JAMA"},{"issue":"5","key":"437_CR18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.cardfail.2010.01.004","volume":"16","author":"D Chiarantini","year":"2010","unstructured":"Chiarantini D, Volpato S, Sioulis F, Bartalucci F, Del Bianco L, Mangani I, et al. Lower extremity performance measures predict long-term prognosis in older patients hospitalized for heart failure. J Card Fail. 2010;16(5):390\u20135. \n                      https:\/\/doi.org\/10.1016\/j.cardfail.2010.01.004\n                      \n                    .","journal-title":"J Card Fail"},{"issue":"5","key":"437_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.cardfail.2014.02.008","volume":"20","author":"CJ Chung","year":"2014","unstructured":"Chung CJ, Wu C, Jones M, Kato TS, Dam TT, Givens RC, et al. Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement. J Card Fail. 2014;20(5):310\u20135. \n                      https:\/\/doi.org\/10.1016\/j.cardfail.2014.02.008\n                      \n                    .","journal-title":"J Card Fail"},{"issue":"11","key":"437_CR20","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.healun.2015.05.027","volume":"34","author":"OL Adejumo","year":"2015","unstructured":"Adejumo OL, Koelling TM, Hummel SL. Nutritional risk index predicts mortality in hospitalized advanced heart failure patients. J Heart Lung Transplant : the official publication of the International Society for Heart Transplantation. 2015;34(11):1385\u20139. \n                      https:\/\/doi.org\/10.1016\/j.healun.2015.05.027\n                      \n                    .","journal-title":"J Heart Lung Transplant : the official publication of the International Society for Heart Transplantation"},{"issue":"3","key":"437_CR21","first-page":"177","volume":"11","author":"V Santilli","year":"2014","unstructured":"Santilli V, Bernetti A, Mangone M, Paoloni M. Clinical definition of sarcopenia. Clin Cases Mineral Bone Metab : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases. 2014;11(3):177\u201380.","journal-title":"Clin Cases Mineral Bone Metab : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases"},{"issue":"7","key":"437_CR22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/eurheartj\/ehs381","volume":"34","author":"S Fulster","year":"2013","unstructured":"Fulster S, Tacke M, Sandek A, Ebner N, Tschope C, Doehner W, et al. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J. 2013;34(7):512\u20139. \n                      https:\/\/doi.org\/10.1093\/eurheartj\/ehs381\n                      \n                    .","journal-title":"Eur Heart J"},{"issue":"1","key":"437_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1177\/0884533616665926","volume":"32","author":"G Yost","year":"2017","unstructured":"Yost G, Bhat G. Relationship between handgrip strength and length of stay for left ventricular assist device implantation. Nutr Clin Pract : official publication of the American Society for Parenteral and Enteral Nutrition. 2017;32(1):98\u2013102. \n                      https:\/\/doi.org\/10.1177\/0884533616665926\n                      \n                    .","journal-title":"Nutr Clin Pract : official publication of the American Society for Parenteral and Enteral Nutrition"},{"issue":"1","key":"437_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0167-5273(02)00233-4","volume":"85","author":"SD Anker","year":"2002","unstructured":"Anker SD, Sharma R. The syndrome of cardiac cachexia. Int J Cardiol. 2002;85(1):51\u201366.","journal-title":"Int J Cardiol"},{"issue":"6","key":"437_CR25","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","volume":"27","author":"WJ Evans","year":"2008","unstructured":"Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr (Edinburgh, Scotland). 2008;27(6):793\u20139. \n                      https:\/\/doi.org\/10.1016\/j.clnu.2008.06.013\n                      \n                    .","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"issue":"3","key":"437_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s13539-013-0105-y","volume":"4","author":"J Farkas","year":"2013","unstructured":"Farkas J, von Haehling S, Kalantar-Zadeh K, Morley JE, Anker SD, Lainscak M. Cachexia as a major public health problem: frequent, costly, and deadly. J Cachexia Sarcopenia Muscle. 2013;4(3):173\u20138. \n                      https:\/\/doi.org\/10.1007\/s13539-013-0105-y\n                      \n                    .","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"9058","key":"437_CR27","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/s0140-6736(96)07015-8","volume":"349","author":"SD Anker","year":"1997","unstructured":"Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet (London, England). 1997;349(9058):1050\u20133. \n                      https:\/\/doi.org\/10.1016\/s0140-6736(96)07015-8\n                      \n                    .","journal-title":"Lancet (London, England)"},{"issue":"3","key":"437_CR28","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0261-5614(02)00214-5","volume":"22","author":"J Kondrup","year":"2003","unstructured":"Kondrup J, Rasmussen HH, Hamberg O, Stanga Z. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr (Edinburgh, Scotland). 2003;22(3):321\u201336.","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"issue":"9","key":"437_CR29","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.amjcard.2016.07.061","volume":"118","author":"GA Heberton","year":"2016","unstructured":"Heberton GA, Nassif M, Bierhals A, Novak E, LaRue SJ, Lima B, et al. Usefulness of psoas muscle area determined by computed tomography to predict mortality or prolonged length of hospital stay in patients undergoing left ventricular assist device implantation. Am J Cardiol. 2016;118(9):1363\u20137. \n                      https:\/\/doi.org\/10.1016\/j.amjcard.2016.07.061\n                      \n                    .","journal-title":"Am J Cardiol"},{"issue":"10","key":"437_CR30","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.cjca.2017.07.145","volume":"33","author":"L Bibas","year":"2017","unstructured":"Bibas L, Saleh E, Alkharji S, Chetrit J, Mullie L, Cantarovich M, et al. Sarcopenia and mortality after heart transplantation. Can J Cardiol. 2017;33(10):S71\u2013S2. \n                      https:\/\/doi.org\/10.1016\/j.cjca.2017.07.145\n                      \n                    .","journal-title":"Can J Cardiol"},{"issue":"4","key":"437_CR31","doi-asserted-by":"publisher","first-page":"e010554","DOI":"10.1161\/jaha.118.010554","volume":"8","author":"A Kumar","year":"2019","unstructured":"Kumar A, Ansari BA, Kim J, Suri A, Gaddam S, Yenigalla S, et al. Axial muscle size as a strong predictor of death in subjects with and without heart failure. J Am Heart Assoc. 2019;8(4):e010554. \n                      https:\/\/doi.org\/10.1161\/jaha.118.010554\n                      \n                    .","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"437_CR32","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ejhf.240","volume":"17","author":"P Rossignol","year":"2015","unstructured":"Rossignol P, Masson S, Barlera S, Girerd N, Castelnovo A, Zannad F, et al. Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials. Eur J Heart Fail. 2015;17(4):424\u201333. \n                      https:\/\/doi.org\/10.1002\/ejhf.240\n                      \n                    .","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"437_CR33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1536\/ihj.17-057","volume":"59","author":"K Tsuchida","year":"2018","unstructured":"Tsuchida K, Fujihara Y, Hiroki J, Hakamata T, Sakai R, Nishida K, et al. Significance of Sarcopenia Evaluation in Acute Decompensated Heart Failure. Skeletal Muscle Mass Index versus Fat-Free Mass Index. Int Heart J. 2018;59(1):143\u20138. \n                      https:\/\/doi.org\/10.1536\/ihj.17-057\n                      \n                    .","journal-title":"Int Heart J"},{"issue":"2","key":"437_CR34","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejim.2015.01.008","volume":"26","author":"T Narumi","year":"2015","unstructured":"Narumi T, Watanabe T, Kadowaki S, Takahashi T, Yokoyama M, Kinoshita D, et al. Sarcopenia evaluated by fat-free mass index is an important prognostic factor in patients with chronic heart failure. Eur J Int Med. 2015;26(2):118\u201322. \n                      https:\/\/doi.org\/10.1016\/j.ejim.2015.01.008\n                      \n                    .","journal-title":"Eur J Int Med"},{"issue":"18","key":"437_CR35","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.jacc.2013.06.046","volume":"62","author":"V Melenovsky","year":"2013","unstructured":"Melenovsky V, Kotrc M, Borlaug BA, Marek T, Kovar J, Malek I, et al. Relationships between right ventricular function, body composition, and prognosis in advanced heart failure. J Am Coll Cardiol. 2013;62(18):1660\u201370. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2013.06.046\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"437_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.clnu.2006.07.009","volume":"26","author":"M Kuzuya","year":"2007","unstructured":"Kuzuya M, Izawa S, Enoki H, Okada K, Iguchi A. Is serum albumin a good marker for malnutrition in the physically impaired elderly? Clin Nutr (Edinburgh, Scotland). 2007;26(1):84\u201390. \n                      https:\/\/doi.org\/10.1016\/j.clnu.2006.07.009\n                      \n                    .","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"issue":"4","key":"437_CR37","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/gastro\/gow013","volume":"4","author":"S Bharadwaj","year":"2016","unstructured":"Bharadwaj S, Ginoya S, Tandon P, Gohel TD, Guirguis J, Vallabh H, et al. Malnutrition: laboratory markers vs nutritional assessment. Gastroenterol Rep (Oxf). 2016;4(4):272\u201380. \n                      https:\/\/doi.org\/10.1093\/gastro\/gow013\n                      \n                    .","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"22","key":"437_CR38","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1136\/heartjnl-2014-305747","volume":"100","author":"P Louren\u00e7o","year":"2014","unstructured":"Louren\u00e7o P, Silva S, Fri\u00f5es F, Alvelos M, Amorim M, Couto M, et al. Low prealbumin is strongly associated with adverse outcome in heart failure. Heart. 2014;100(22):1780\u20135. \n                      https:\/\/doi.org\/10.1136\/heartjnl-2014-305747\n                      \n                    .","journal-title":"Heart."},{"issue":"1","key":"437_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jchf.2018.07.015","volume":"7","author":"S von Haehling","year":"2019","unstructured":"von Haehling S, Ebner N, Evertz R, Ponikowski P, Anker SD. Iron deficiency in heart failure: an overview. JACC Heart failure. 2019;7(1):36\u201346. \n                      https:\/\/doi.org\/10.1016\/j.jchf.2018.07.015\n                      \n                    .","journal-title":"JACC Heart failure"},{"issue":"10","key":"437_CR40","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/ajh.24820","volume":"92","author":"MD Cappellini","year":"2017","unstructured":"Cappellini MD, Comin-Colet J, de Francisco A, Dignass A, Doehner W, Lam CS, et al. Iron deficiency across chronic inflammatory conditions: international expert opinion on definition, diagnosis, and management. Am J Hematol. 2017;92(10):1068\u201378. \n                      https:\/\/doi.org\/10.1002\/ajh.24820\n                      \n                    .","journal-title":"Am J Hematol"},{"issue":"2","key":"437_CR41","first-page":"281","volume":"25","author":"FE Boulton","year":"1973","unstructured":"Boulton FE. The myoglobin content of human skeletal muscle. Br J Haematol. 1973;25(2):281.","journal-title":"Br J Haematol"},{"issue":"7","key":"437_CR42","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/ejhf.467","volume":"18","author":"M Stugiewicz","year":"2016","unstructured":"Stugiewicz M, Tkaczyszyn M, Kasztura M, Banasiak W, Ponikowski P, Jankowska EA. The influence of iron deficiency on the functioning of skeletal muscles: experimental evidence and clinical implications. Eur J Heart Fail. 2016;18(7):762\u201373. \n                      https:\/\/doi.org\/10.1002\/ejhf.467\n                      \n                    .","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"437_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/00015385.2017.1351239","volume":"73","author":"P Martens","year":"2018","unstructured":"Martens P, Nijst P, Verbrugge FH, Smeets K, Dupont M, Mullens W. Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction. Acta Cardiol. 2018;73(2):115\u201323. \n                      https:\/\/doi.org\/10.1080\/00015385.2017.1351239\n                      \n                    .","journal-title":"Acta Cardiol"},{"issue":"7","key":"437_CR44","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911\u201330. \n                      https:\/\/doi.org\/10.1210\/jc.2011-0385\n                      \n                    .","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"437_CR45","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1016\/j.jacc.2016.03.508","volume":"67","author":"KK Witte","year":"2016","unstructured":"Witte KK, Byrom R, Gierula J, Paton MF, Jamil HA, Lowry JE, et al. Effects of vitamin D on cardiac function in patients with chronic HF: the VINDICATE study. J Am Coll Cardiol. 2016;67(22):2593\u2013603. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2016.03.508\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"437_CR46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11914-014-0193-4","volume":"12","author":"KM Sanders","year":"2014","unstructured":"Sanders KM, Scott D, Ebeling PR. Vitamin D deficiency and its role in muscle-bone interactions in the elderly. Curr Osteoporos Rep. 2014;12(1):74\u201381. \n                      https:\/\/doi.org\/10.1007\/s11914-014-0193-4\n                      \n                    .","journal-title":"Curr Osteoporos Rep"},{"issue":"12","key":"437_CR47","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1210\/jc.2003-030604","volume":"88","author":"M Visser","year":"2003","unstructured":"Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the longitudinal aging study Amsterdam. J Clin Endocrinol Metab. 2003;88(12):5766\u201372. \n                      https:\/\/doi.org\/10.1210\/jc.2003-030604\n                      \n                    .","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"437_CR48","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1210\/jc.2006-1525","volume":"92","author":"IS Wicherts","year":"2007","unstructured":"Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J, et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab. 2007;92(6):2058\u201365. \n                      https:\/\/doi.org\/10.1210\/jc.2006-1525\n                      \n                    .","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"437_CR49","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.numecd.2017.11.008","volume":"28","author":"S Costanzo","year":"2018","unstructured":"Costanzo S, De Curtis A, Di Castelnuovo A, Persichillo M, Bonaccio M, Pounis G, et al. Serum vitamin D deficiency and risk of hospitalization for heart failure: prospective results from the Moli-sani study. Nutr Metab Cardiovasc Dis : NMCD. 2018;28(3):298\u2013307. \n                      https:\/\/doi.org\/10.1016\/j.numecd.2017.11.008\n                      \n                    .","journal-title":"Nutr Metab Cardiovasc Dis : NMCD"},{"issue":"6","key":"437_CR50","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cardfail.2007.03.011","volume":"13","author":"JT Heywood","year":"2007","unstructured":"Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007;13(6):422\u201330. \n                      https:\/\/doi.org\/10.1016\/j.cardfail.2007.03.011\n                      \n                    .","journal-title":"J Card Fail"},{"issue":"23","key":"437_CR51","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1136\/heartjnl-2016-310794","volume":"103","author":"C Tuegel","year":"2017","unstructured":"Tuegel C, Bansal N. Heart failure in patients with kidney disease. Heart. 2017;103(23):1848\u201353. \n                      https:\/\/doi.org\/10.1136\/heartjnl-2016-310794\n                      \n                    .","journal-title":"Heart."},{"issue":"5","key":"437_CR52","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1053\/j.ajkd.2003.12.049","volume":"43","author":"MG Shlipak","year":"2004","unstructured":"Shlipak MG, Stehman-Breen C, Fried LF, Song X, Siscovick D, Fried LP, et al. The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis : the official journal of the National Kidney Foundation. 2004;43(5):861\u20137.","journal-title":"Am J Kidney Dis : the official journal of the National Kidney Foundation"},{"issue":"11","key":"437_CR53","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1111\/jgs.15124","volume":"65","author":"MS Maurer","year":"2017","unstructured":"Maurer MS, Horn E, Reyentovich A, Dickson VV, Pinney S, Goldwater D, et al. Can a left ventricular assist device in individuals with advanced systolic heart failure improve or reverse frailty? J Am Geriatr Soc. 2017;65(11):2383\u201390. \n                      https:\/\/doi.org\/10.1111\/jgs.15124\n                      \n                    .","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"437_CR54","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/ehf2.12185","volume":"4","author":"R Jenkins","year":"2017","unstructured":"Jenkins R, Mandarano L, Gugathas S, Kaski JC, Anderson L, Banerjee D. Impaired renal function affects clinical outcomes and management of patients with heart failure. ESC heart failure. 2017;4(4):576\u201384. \n                      https:\/\/doi.org\/10.1002\/ehf2.12185\n                      \n                    .","journal-title":"ESC heart failure"},{"issue":"5 Suppl 3","key":"437_CR55","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1053\/j.ajkd.2006.03.010","volume":"47","author":"KDOQI","year":"2006","unstructured":"KDOQI. Clinical practice guidelines and clinical practice recommendations for Anemia in chronic kidney disease. Am J Kidney Dis : the official journal of the National Kidney Foundation. 2006;47(5 Suppl 3):S11\u2013145. \n                      https:\/\/doi.org\/10.1053\/j.ajkd.2006.03.010\n                      \n                    .","journal-title":"Am J Kidney Dis : the official journal of the National Kidney Foundation"},{"issue":"2","key":"437_CR56","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/ndt\/gfw466","volume":"33","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Hellberg M, Svensson P, Hoglund P, Clyne N. Sarcopenia and relationships between muscle mass, measured glomerular filtration rate and physical function in patients with chronic kidney disease stages 3-5. Nephrol Dialysis Transplant : official publication of the European Dialysis and Transplant Association - European Renal Association. 2018;33(2):342\u20138. \n                      https:\/\/doi.org\/10.1093\/ndt\/gfw466\n                      \n                    .","journal-title":"Nephrol Dialysis Transplant : official publication of the European Dialysis and Transplant Association - European Renal Association"},{"issue":"10","key":"437_CR57","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/ndt\/gfv133","volume":"30","author":"RA Pereira","year":"2015","unstructured":"Pereira RA, Cordeiro AC, Avesani CM, Carrero JJ, Lindholm B, Amparo FC, et al. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dialysis Transplant : official publication of the European Dialysis and Transplant Association - European Renal Association. 2015;30(10):1718\u201325. \n                      https:\/\/doi.org\/10.1093\/ndt\/gfv133\n                      \n                    .","journal-title":"Nephrol Dialysis Transplant : official publication of the European Dialysis and Transplant Association - European Renal Association"},{"issue":"9","key":"437_CR58","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1053\/euhj.1998.1446","volume":"20","author":"SD Anker","year":"1999","unstructured":"Anker SD, Ponikowski PP, Clark AL, Leyva F, Rauchhaus M, Kemp M, et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J. 1999;20(9):683\u201393. \n                      https:\/\/doi.org\/10.1053\/euhj.1998.1446\n                      \n                    .","journal-title":"Eur Heart J"},{"issue":"3","key":"437_CR59","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/gerona\/59.3.m242","volume":"59","author":"M Cesari","year":"2004","unstructured":"Cesari M, Penninx BW, Pahor M, Lauretani F, Corsi AM, Rhys Williams G, et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59(3):242\u20138. \n                      https:\/\/doi.org\/10.1093\/gerona\/59.3.m242\n                      \n                    .","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"437_CR60","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40001-017-0266-9","volume":"22","author":"AL Bian","year":"2017","unstructured":"Bian AL, Hu HY, Rong YD, Wang J, Wang JX, Zhou XZ. A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-alpha. Eur J Med Res. 2017;22(1):25. \n                      https:\/\/doi.org\/10.1186\/s40001-017-0266-9\n                      \n                    .","journal-title":"Eur J Med Res"},{"issue":"1","key":"437_CR61","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2017-000730","volume":"5","author":"A Yoshihisa","year":"2018","unstructured":"Yoshihisa A, Kanno Y, Watanabe S, Yokokawa T, Abe S, Miyata M, et al. Impact of nutritional indices on mortality in patients with heart failure. Open heart. 2018;5(1):e000730. \n                      https:\/\/doi.org\/10.1136\/openhrt-2017-000730\n                      \n                    .","journal-title":"Open heart"},{"issue":"3","key":"437_CR62","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2174\/157340309788970306","volume":"5","author":"G Castellano","year":"2009","unstructured":"Castellano G, Affuso F, Conza PD, Fazio S. The GH\/IGF-1 Axis and heart failure. Curr Cardiol Rev. 2009;5(3):203\u201315. \n                      https:\/\/doi.org\/10.2174\/157340309788970306\n                      \n                    .","journal-title":"Curr Cardiol Rev"},{"issue":"2","key":"437_CR63","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0735-1097(01)01385-7","volume":"38","author":"SD Anker","year":"2001","unstructured":"Anker SD, Volterrani M, Pflaum CD, Strasburger CJ, Osterziel KJ, Doehner W, et al. Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol. 2001;38(2):443\u201352.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"437_CR64","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1210\/jc.2009-0533","volume":"94","author":"A Cittadini","year":"2009","unstructured":"Cittadini A, Saldamarco L, Marra AM, Arcopinto M, Carlomagno G, Imbriaco M, et al. Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction. J Clin Endocrinol Metab. 2009;94(9):3329\u201336. \n                      https:\/\/doi.org\/10.1210\/jc.2009-0533\n                      \n                    .","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"437_CR65","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ejhf.459","volume":"18","author":"SS Bhandari","year":"2016","unstructured":"Bhandari SS, Narayan H, Jones DJ, Suzuki T, Struck J, Bergmann A, et al. Plasma growth hormone is a strong predictor of risk at 1 year in acute heart failure. Eur J Heart Fail. 2016;18(3):281\u20139. \n                      https:\/\/doi.org\/10.1002\/ejhf.459\n                      \n                    .","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"437_CR66","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/hrt.2006.090092","volume":"93","author":"S Hassfeld","year":"2007","unstructured":"Hassfeld S, Eichhorn C, Stehr K, Naegele H, Geier C, Steeg M, et al. Insulin-like growth factor-binding proteins 2 and 3 are independent predictors of a poor prognosis in patients with dilated cardiomyopathy. Heart. 2007;93(3):359\u201360. \n                      https:\/\/doi.org\/10.1136\/hrt.2006.090092\n                      \n                    .","journal-title":"Heart."},{"issue":"2","key":"437_CR67","doi-asserted-by":"publisher","first-page":"104","DOI":"10.7326\/0003-4819-146-2-200701160-00005","volume":"146","author":"H Liu","year":"2007","unstructured":"Liu H, Bravata DM, Olkin I, Nayak S, Roberts B, Garber AM, et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med. 2007;146(2):104\u201315.","journal-title":"Ann Intern Med"},{"issue":"1","key":"437_CR68","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1743-6109.2012.02783.x","volume":"10","author":"J Buvat","year":"2013","unstructured":"Buvat J, Maggi M, Guay A, Torres LO. Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. J Sex Med. 2013;10(1):245\u201384. \n                      https:\/\/doi.org\/10.1111\/j.1743-6109.2012.02783.x\n                      \n                    .","journal-title":"J Sex Med"},{"issue":"3","key":"437_CR69","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3109\/13685538.2013.807427","volume":"16","author":"E Kalicinska","year":"2013","unstructured":"Kalicinska E, Wojtas K, Majda J, Doehner W, von Haehling S, Banasiak W, et al. Anabolic deficiencies in men with systolic heart failure: do co-morbidities and therapies really contribute significantly? Aging Male : the official journal of the International Society for the Study of the Aging Male. 2013;16(3):123\u201331. \n                      https:\/\/doi.org\/10.3109\/13685538.2013.807427\n                      \n                    .","journal-title":"Aging Male : the official journal of the International Society for the Study of the Aging Male"},{"issue":"5","key":"437_CR70","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/aja.2011.26","volume":"13","author":"HY Wu","year":"2011","unstructured":"Wu HY, Wang XF, Wang JH, Li JY. Testosterone level and mortality in elderly men with systolic chronic heart failure. Asian J Androl. 2011;13(5):759\u201363. \n                      https:\/\/doi.org\/10.1038\/aja.2011.26\n                      \n                    .","journal-title":"Asian J Androl"},{"issue":"5","key":"437_CR71","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cardfail.2008.12.011","volume":"15","author":"EA Jankowska","year":"2009","unstructured":"Jankowska EA, Filippatos G, Ponikowska B, Borodulin-Nadzieja L, Anker SD, Banasiak W, et al. Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure. J Card Fail. 2009;15(5):442\u201350. \n                      https:\/\/doi.org\/10.1016\/j.cardfail.2008.12.011\n                      \n                    .","journal-title":"J Card Fail"},{"issue":"S1","key":"437_CR72","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S1567-4215(07)60413-5","volume":"6","author":"EA Jankowska","year":"2007","unstructured":"Jankowska EA, Biel B, Ponikowska B, Borodulin-Nadzieja L, Petruk-Kowalczyk J, Banasiak W, et al. 679 Reduction in serum testosterone deteriorates exercise capacity in men in the course of chronic heart failure. Eur J Heart Fail Suppl. 2007;6(S1):148. \n                      https:\/\/doi.org\/10.1016\/S1567-4215(07)60413-5\n                      \n                    .","journal-title":"Eur J Heart Fail Suppl"},{"issue":"17","key":"437_CR73","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1161\/circulationaha.106.649426","volume":"114","author":"EA Jankowska","year":"2006","unstructured":"Jankowska EA, Biel B, Majda J, Szklarska A, Lopuszanska M, Medras M, et al. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation. 2006;114(17):1829\u201337. \n                      https:\/\/doi.org\/10.1161\/circulationaha.106.649426\n                      \n                    .","journal-title":"Circulation."},{"issue":"3","key":"437_CR74","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/jcsm.12118","volume":"7","author":"G Loncar","year":"2016","unstructured":"Loncar G, Springer J, Anker M, Doehner W, Lainscak M. Cardiac cachexia: hic et nunc. J Cachexia Sarcopenia Muscle. 2016;7(3):246\u201360. \n                      https:\/\/doi.org\/10.1002\/jcsm.12118\n                      \n                    .","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"437_CR75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1365-2265.2009.03730.x","volume":"73","author":"M Serra-Prat","year":"2010","unstructured":"Serra-Prat M, Palomera E, Roca M, Puig-Domingo M. Long-term effect of ghrelin on nutritional status and functional capacity in the elderly: a population-based cohort study. Clin Endocrinol. 2010;73(1):41\u20137. \n                      https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03730.x\n                      \n                    .","journal-title":"Clin Endocrinol"},{"issue":"17","key":"437_CR76","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1161\/hc4201.097836","volume":"104","author":"N Nagaya","year":"2001","unstructured":"Nagaya N, Uematsu M, Kojima M, Date Y, Nakazato M, Okumura H, et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic\/catabolic factors. Circulation. 2001;104(17):2034\u20138.","journal-title":"Circulation."},{"issue":"12","key":"437_CR77","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/ejhf.400","volume":"17","author":"L Steinbeck","year":"2015","unstructured":"Steinbeck L, Ebner N, Valentova M, Bekfani T, Elsner S, Dahinden P, et al. Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur J Heart Fail. 2015;17(12):1283\u201393. \n                      https:\/\/doi.org\/10.1002\/ejhf.400\n                      \n                    .","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"437_CR78","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/eurjhf\/hfp046","volume":"11","author":"JP Araujo","year":"2009","unstructured":"Araujo JP, Lourenco P, Rocha-Goncalves F, Ferreira A, Bettencourt P. Adiponectin is increased in cardiac cachexia irrespective of body mass index. Eur J Heart Fail. 2009;11(6):567\u201372. \n                      https:\/\/doi.org\/10.1093\/eurjhf\/hfp046\n                      \n                    .","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"437_CR79","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.numecd.2013.04.015","volume":"24","author":"T Szabo","year":"2014","unstructured":"Szabo T, Scherbakov N, Sandek A, Kung T, von Haehling S, Lainscak M, et al. Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis. Nutr Metab Cardiovasc Dis : NMCD. 2014;24(1):50\u20136. \n                      https:\/\/doi.org\/10.1016\/j.numecd.2013.04.015\n                      \n                    .","journal-title":"Nutr Metab Cardiovasc Dis : NMCD"},{"issue":"6","key":"437_CR80","doi-asserted-by":"publisher","first-page":"H1973","DOI":"10.1152\/ajpheart.00200.2011","volume":"300","author":"A Breitbart","year":"2011","unstructured":"Breitbart A, Auger-Messier M, Molkentin JD, Heineke J. Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting. Am J Physiol Heart Circ Physiol. 2011;300(6):H1973\u2013H82. \n                      https:\/\/doi.org\/10.1152\/ajpheart.00200.2011\n                      \n                    .","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"437_CR81","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/eurjhf\/hfp020","volume":"11","author":"K Lenk","year":"2009","unstructured":"Lenk K, Schur R, Linke A, Erbs S, Matsumoto Y, Adams V, et al. Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model. Eur J Heart Fail. 2009;11(4):342\u20138. \n                      https:\/\/doi.org\/10.1093\/eurjhf\/hfp020\n                      \n                    .","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"437_CR82","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.cardfail.2019.03.007","volume":"25","author":"AR Vest","year":"2019","unstructured":"\u2022 Vest AR, Chan M, Deswal A, Givertz MM, Lekavich C, Lennie T, et al. Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee. J Card Fail. 2019;25(5):380\u2013400. \n                      https:\/\/doi.org\/10.1016\/j.cardfail.2019.03.007\n                      \n                    \n                              This article suggests an approach to the assessment of HF patients (both inpatients and outpatients) with malnutrition in combination with either cachexia and obesity and a management strategy for each cohort.","journal-title":"J Card Fail"},{"issue":"1","key":"437_CR83","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13539-010-0008-0","volume":"1","author":"P Rozentryt","year":"2010","unstructured":"Rozentryt P, von Haehling S, Lainscak M, Nowak JU, Kalantar-Zadeh K, Polonski L, et al. The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study. J Cachexia Sarcopenia Muscle. 2010;1(1):35\u201342. \n                      https:\/\/doi.org\/10.1007\/s13539-010-0008-0\n                      \n                    .","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"11a","key":"437_CR84","doi-asserted-by":"publisher","first-page":"104e","DOI":"10.1016\/j.amjcard.2008.03.008","volume":"101","author":"R Aquilani","year":"2008","unstructured":"Aquilani R, Viglio S, Iadarola P, Opasich C, Testa A, Dioguardi FS, et al. Oral amino acid supplements improve exercise capacities in elderly patients with chronic heart failure. Am J Cardiol. 2008;101(11a):104e\u201310e. \n                      https:\/\/doi.org\/10.1016\/j.amjcard.2008.03.008\n                      \n                    .","journal-title":"Am J Cardiol"},{"issue":"1","key":"437_CR85","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12020-012-9676-1","volume":"42","author":"SC Forbes","year":"2012","unstructured":"Forbes SC, Little JP, Candow DG. Exercise and nutritional interventions for improving aging muscle health. Endocrine. 2012;42(1):29\u201338. \n                      https:\/\/doi.org\/10.1007\/s12020-012-9676-1\n                      \n                    .","journal-title":"Endocrine."},{"issue":"2","key":"437_CR86","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s13539-012-0096-0","volume":"4","author":"DW Gould","year":"2013","unstructured":"Gould DW, Lahart I, Carmichael AR, Koutedakis Y, Metsios GS. Cancer cachexia prevention via physical exercise: molecular mechanisms. J Cachexia Sarcopenia Muscle. 2013;4(2):111\u201324. \n                      https:\/\/doi.org\/10.1007\/s13539-012-0096-0\n                      \n                    .","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"437_CR87","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1177\/1741826711402735","volume":"19","author":"K Lenk","year":"2012","unstructured":"Lenk K, Erbs S, Hollriegel R, Beck E, Linke A, Gielen S, et al. Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure. Eur J Prev Cardiol. 2012;19(3):404\u201311. \n                      https:\/\/doi.org\/10.1177\/1741826711402735\n                      \n                    .","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"437_CR88","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/jcsm.12191","volume":"8","author":"AL Clark","year":"2017","unstructured":"Clark AL, Coats AJS, Krum H, Katus HA, Mohacsi P, Salekin D, et al. Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial. J Cachexia Sarcopenia Muscle. 2017;8(4):549\u201356. \n                      https:\/\/doi.org\/10.1002\/jcsm.12191\n                      \n                    .","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"9363","key":"437_CR89","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/s0140-6736(03)12892-9","volume":"361","author":"SD Anker","year":"2003","unstructured":"Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet (London, England). 2003;361(9363):1077\u201383. \n                      https:\/\/doi.org\/10.1016\/s0140-6736(03)12892-9\n                      \n                    .","journal-title":"Lancet (London, England)"},{"issue":"4","key":"437_CR90","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13539-014-0155-9","volume":"5","author":"T Khawaja","year":"2014","unstructured":"Khawaja T, Chokshi A, Ji R, Kato TS, Xu K, Zizola C, et al. Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone\/insulin-like growth factor-1 axis signaling in patients with advanced heart failure. J Cachexia Sarcopenia Muscle. 2014;5(4):297\u2013305. \n                      https:\/\/doi.org\/10.1007\/s13539-014-0155-9\n                      \n                    .","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"25","key":"437_CR91","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361(25):2436\u201348. \n                      https:\/\/doi.org\/10.1056\/NEJMoa0908355\n                      \n                    .","journal-title":"N Engl J Med"},{"issue":"9","key":"437_CR92","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.jamda.2015.05.021","volume":"16","author":"JM Bauer","year":"2015","unstructured":"Bauer JM, Verlaan S, Bautmans I, Brandt K, Donini LM, Maggio M, et al. Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc. 2015;16(9):740\u20137. \n                      https:\/\/doi.org\/10.1016\/j.jamda.2015.05.021\n                      \n                    .","journal-title":"J Am Med Dir Assoc"},{"issue":"25","key":"437_CR93","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1161\/01.Cir.0000077913.60364.D2","volume":"107","author":"ES Chung","year":"2003","unstructured":"Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation. 2003;107(25):3133\u201340. \n                      https:\/\/doi.org\/10.1161\/01.Cir.0000077913.60364.D2\n                      \n                    .","journal-title":"Circulation."},{"issue":"13","key":"437_CR94","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1161\/01.Cir.0000124490.27666.B2","volume":"109","author":"DL Mann","year":"2004","unstructured":"Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the randomized Etanercept worldwide evaluation (RENEWAL). Circulation. 2004;109(13):1594\u2013602. \n                      https:\/\/doi.org\/10.1161\/01.Cir.0000124490.27666.B2\n                      \n                    .","journal-title":"Circulation."},{"issue":"10","key":"437_CR95","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","volume":"139","author":"M Everett Brendan","year":"2019","unstructured":"Everett Brendan M, Cornel Jan H, Lainscak M, Anker Stefan D, Abbate A, Thuren T, et al. Anti-inflammatory therapy with Canakinumab for the prevention of hospitalization for heart failure. Circulation. 2019;139(10):1289\u201399. \n                      https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038010\n                      \n                    .","journal-title":"Circulation."},{"issue":"10","key":"437_CR96","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jacc.2009.04.078","volume":"54","author":"G Caminiti","year":"2009","unstructured":"Caminiti G, Volterrani M, Iellamo F, Marazzi G, Massaro R, Miceli M, et al. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol. 2009;54(10):919\u201327. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2009.04.078\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"437_CR97","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jacc.2010.03.090","volume":"56","author":"F Iellamo","year":"2010","unstructured":"Iellamo F, Volterrani M, Caminiti G, Karam R, Massaro R, Fini M, et al. Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. J Am Coll Cardiol. 2010;56(16):1310\u20136. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2010.03.090\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"437_CR98","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.ahj.2012.09.016","volume":"164","author":"M Stout","year":"2012","unstructured":"Stout M, Tew GA, Doll H, Zwierska I, Woodroofe N, Channer KS, et al. Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: a double-blind randomized controlled feasibility study. Am Heart J. 2012;164(6):893\u2013901. \n                      https:\/\/doi.org\/10.1016\/j.ahj.2012.09.016\n                      \n                    .","journal-title":"Am Heart J"},{"issue":"4","key":"437_CR99","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/s1470-2045(13)70055-x","volume":"14","author":"AS Dobs","year":"2013","unstructured":"Dobs AS, Boccia RV, Croot CC, Gabrail NY, Dalton JT, Hancock ML, et al. Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial. Lancet Oncol. 2013;14(4):335\u201345. \n                      https:\/\/doi.org\/10.1016\/s1470-2045(13)70055-x\n                      \n                    .","journal-title":"Lancet Oncol"},{"issue":"24","key":"437_CR100","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1161\/01.Cir.0000149746.62908.Bb","volume":"110","author":"N Nagaya","year":"2004","unstructured":"Nagaya N, Moriya J, Yasumura Y, Uematsu M, Ono F, Shimizu W, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation. 2004;110(24):3674\u20139. \n                      https:\/\/doi.org\/10.1161\/01.Cir.0000149746.62908.Bb\n                      \n                    .","journal-title":"Circulation."},{"issue":"3","key":"437_CR101","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/cncr.31128","volume":"124","author":"N Katakami","year":"2018","unstructured":"Katakami N, Uchino J, Yokoyama T, Naito T, Kondo M, Yamada K, et al. Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04). Cancer. 2018;124(3):606\u201316. \n                      https:\/\/doi.org\/10.1002\/cncr.31128\n                      \n                    .","journal-title":"Cancer."},{"issue":"1","key":"437_CR102","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/jcsm.12106","volume":"7","author":"N Ebner","year":"2016","unstructured":"Ebner N, von Haehling S. Unlocking the wasting enigma: highlights from the 8th Cachexia conference. J Cachexia Sarcopenia Muscle. 2016;7(1):90\u20134. \n                      https:\/\/doi.org\/10.1002\/jcsm.12106\n                      \n                    .","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"437_CR103","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1164\/rccm.201802-0286OC","volume":"199","author":"MI Polkey","year":"2019","unstructured":"Polkey MI, Praestgaard J, Berwick A, Franssen FME, Singh D, Steiner MC, et al. Activin type II receptor blockade for treatment of muscle depletion in chronic obstructive pulmonary disease. A randomized trial. Am J Respir Crit Care Med. 2019;199(3):313\u201320. \n                      https:\/\/doi.org\/10.1164\/rccm.201802-0286OC\n                      \n                    .","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-019-00437-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11897-019-00437-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-019-00437-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T23:11:11Z","timestamp":1602371471000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11897-019-00437-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":103,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["437"],"URL":"https:\/\/doi.org\/10.1007\/s11897-019-00437-y","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"value":"1546-9530","type":"print"},{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"12 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}